DSM-Firmenich AG (LON:0AC9)

London flag London · Delayed Price · Currency is GBP · Price in EUR
89.98
-0.86 (-0.94%)
At close: Jul 11, 2025
-18.75%
Market Cap20.27B
Revenue (ttm)10.58B
Net Income (ttm)206.74M
Shares Outn/a
EPS (ttm)0.78
PE Ratio98.07
Forward PE22.06
Dividend2.12 (2.36%)
Ex-Dividend DateMay 8, 2025
Volume147,154
Average Volume56,653
Open91.10
Previous Close90.84
Day's Range89.52 - 91.14
52-Week Range82.76 - 125.00
Betan/a
RSI35.61
Earnings DateJul 31, 2025

About DSM-Firmenich AG

DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through four segments: Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and s... [Read more]

Industry Chemicals and Allied Products
Founded 1902
Employees 26,301
Stock Exchange London Stock Exchange
Ticker Symbol 0AC9
Full Company Profile

Financial Performance

In 2024, DSM-Firmenich AG's revenue was 12.80 billion, an increase of 20.44% compared to the previous year's 10.63 billion. Earnings were 250.00 million, a decrease of -88.27%.

Financial numbers in EUR Financial Statements

News

There is no news available yet.